Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Analysis of topographical distribution of prostate cancer and related pathological findings in prostatectomy specimens using cMDX document architecture.

Eminaga O, Semjonow A, Eltze E, Bettendorf O, Schultheis A, Warnecke-Eberz U, Akbarov I, Wille S, Engelmann U.

J Biomed Inform. 2016 Feb;59:240-7. doi: 10.1016/j.jbi.2015.12.009. Epub 2015 Dec 17.

PMID:
26707451
2.

Comparison of structural genetics of non-schistosoma-associated squamous cell carcinoma of the urinary bladder.

Molitor M, Junker K, Eltze E, Toma M, Denzinger S, Siegert S, Knuechel R, Gaisa NT.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):8143-58. eCollection 2015.

3.

Preoperative Serum Prostate-Specific Antigen Levels Vary According to the Topographical Distribution of Prostate Cancer in Prostatectomy Specimens.

Eminaga O, Hinkelammert R, Abbas M, Wötzel F, Eltze E, Bettendorf O, Boegemann M, Semjonow A.

Urology. 2015 Oct;86(4):798-804. doi: 10.1016/j.urology.2015.07.029. Epub 2015 Aug 6.

PMID:
26255036
4.

Exploring prostate cancer genome reveals simultaneous losses of PTEN, FAS and PAPSS2 in patients with PSA recurrence after radical prostatectomy.

Ibeawuchi C, Schmidt H, Voss R, Titze U, Abbas M, Neumann J, Eltze E, Hoogland AM, Jenster G, Brandt B, Semjonow A.

Int J Mol Sci. 2015 Feb 11;16(2):3856-69. doi: 10.3390/ijms16023856.

5.

Preoperative prostate-specific antigen isoform p2PSA ≤ 22.5 pg/ml predicts advanced prostate cancer in patients undergoing radical prostatectomy.

Eminaga O, Bögemann M, Breil B, Titze U, Wötzel F, Eltze E, Bettendorf O, Semjonow A.

Urol Oncol. 2014 Nov;32(8):1317-26. doi: 10.1016/j.urolonc.2014.04.018. Epub 2014 Jun 2.

PMID:
24893699
6.

Prostate cancers detected on repeat prostate biopsies show spatial distributions that differ from those detected on the initial biopsies.

Eminaga O, Hinkelammert R, Abbas M, Titze U, Eltze E, Bettendorf O, Wötzel F, Bögemann M, Semjonow A.

BJU Int. 2015 Jul;116(1):57-64. doi: 10.1111/bju.12691. Epub 2015 Apr 17.

PMID:
24552505
7.

Tumor percentage but not number of tumor foci predicts disease-free survival after radical prostatectomy especially in high-risk patients.

Hinkelammert R, Eminaga O, Bettendorf O, Eltze E, Abbas M, Hertle L, Semjonow A.

Urol Oncol. 2014 May;32(4):403-12. doi: 10.1016/j.urolonc.2013.10.001. Epub 2013 Dec 12.

PMID:
24332639
8.

[A Mycotic Pulmonary Artery Aneurysm in an Intravenous Drug User].

Huwer H, Gamrekeli A, Schäfer H, Eltze E.

Zentralbl Chir. 2015 Jun;140(3):334-6. doi: 10.1055/s-0033-1350694. Epub 2013 Oct 16. German. No abstract available.

PMID:
24132673
9.

Genome-wide investigation of multifocal and unifocal prostate cancer-are they genetically different?

Ibeawuchi C, Schmidt H, Voss R, Titze U, Abbas M, Neumann J, Eltze E, Hoogland AM, Jenster G, Brandt B, Semjonow A.

Int J Mol Sci. 2013 Jun 3;14(6):11816-29. doi: 10.3390/ijms140611816.

10.

High-grade prostatic intraepithelial neoplasia (HGPIN) and topographical distribution in 1,374 prostatectomy specimens: existence of HGPIN near prostate cancer.

Eminaga O, Hinkelammert R, Abbas M, Titze U, Eltze E, Bettendorf O, Semjonow A.

Prostate. 2013 Jul;73(10):1115-22. doi: 10.1002/pros.22660. Epub 2013 Mar 26.

PMID:
23532797
11.

The presence of positive surgical margins in patients with organ-confined prostate cancer results in biochemical recurrence at a similar rate to that in patients with extracapsular extension and PSA ≤ 10 ng/ml.

Eminaga O, Hinkelammert R, Titze U, Abbas M, Eltze E, Bettendorf O, Semjonow A.

Urol Oncol. 2014 Jan;32(1):32.e17-25. doi: 10.1016/j.urolonc.2012.11.021. Epub 2013 Feb 19.

PMID:
23434425
12.

CMDX©-based single source information system for simplified quality management and clinical research in prostate cancer.

Eminaga O, Abbas M, Hinkelammert R, Titze U, Bettendorf O, Eltze E, Ozgür E, Semjonow A.

BMC Med Inform Decis Mak. 2012 Dec 3;12:141. doi: 10.1186/1472-6947-12-141.

13.

[Pulmonary paraganglioma: case report and literature review].

Huwer H, Kalweit G, Schäfer H, Eltze E.

Pneumologie. 2011 Dec;65(12):742-4. doi: 10.1055/s-0031-1286635. Epub 2011 Nov 2. Review. German.

14.

Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer.

Tavoosidana G, Ronquist G, Darmanis S, Yan J, Carlsson L, Wu D, Conze T, Ek P, Semjonow A, Eltze E, Larsson A, Landegren UD, Kamali-Moghaddam M.

Proc Natl Acad Sci U S A. 2011 May 24;108(21):8809-14. doi: 10.1073/pnas.1019330108. Epub 2011 May 9.

15.

MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening.

Wach S, Nolte E, Szczyrba J, Stöhr R, Hartmann A, Ørntoft T, Dyrskjøt L, Eltze E, Wieland W, Keck B, Ekici AB, Grässer F, Wullich B.

Int J Cancer. 2012 Feb 1;130(3):611-21. doi: 10.1002/ijc.26064. Epub 2011 May 9.

16.

Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer.

Gaisa NT, Braunschweig T, Reimer N, Bornemann J, Eltze E, Siegert S, Toma M, Villa L, Hartmann A, Knuechel R.

Virchows Arch. 2011 Mar;458(3):301-12. doi: 10.1007/s00428-010-1017-2. Epub 2010 Dec 7.

PMID:
21136076
17.

Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens.

Eminaga O, Hinkelammert R, Semjonow A, Neumann J, Abbas M, Koepke T, Bettendorf O, Eltze E, Dugas M.

BMC Med Inform Decis Mak. 2010 Nov 15;10:71. doi: 10.1186/1472-6947-10-71.

18.

Negative predictive value of systematic ultrasound-guided prostate biopsy: which tumours do we miss?

Köpke T, Oberpenning F, Bettendorf O, Eltze E, Herrmann E, Hertle L, Weining C, Wulfing C, Semjonow A.

Anticancer Res. 2010 May;30(5):1823-7.

PMID:
20592386
19.

BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood.

Bednarz N, Eltze E, Semjonow A, Rink M, Andreas A, Mulder L, Hannemann J, Fisch M, Pantel K, Weier HU, Bielawski KP, Brandt B.

Clin Cancer Res. 2010 Jul 1;16(13):3340-8. doi: 10.1158/1078-0432.CCR-10-0150. Epub 2010 Jun 30.

20.

Pre-analytical in-vitro stability of [-2]proPSA in blood and serum.

Semjonow A, Köpke T, Eltze E, Pepping-Schefers B, Bürgel H, Darte C.

Clin Biochem. 2010 Jul;43(10-11):926-8. doi: 10.1016/j.clinbiochem.2010.04.062. Epub 2010 May 8.

PMID:
20450900
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk